Article
Identification of an epigenetic prognostic signature for patients with lower‐grade gliomas
18 Jan 2021
Abstract excerpt
INTRODUCTION: Glioma is the most common malignant primary brain tumor with survival outcome for patients with lower-grade gliomas (LGGs) being quite variable. Epigenetic modifications in LGGs appear tightly linked to patient clinical outcomes but are not commonly used as clinical tools. AIMS: We aimed to derive an epigenetic enzyme gene signature for LGGs that would allow for improved clinical risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
